Examining heart and lung health in extremely premature infants
Official title: Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants: A Prospective Cross-sectional Study
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT04114435 · Data updated 2026-11-12
This study looks at the heart and lung health of extremely premature babies to see if they have problems that could affect their future health and development.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Days to 5 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | October 12, 2019 |
| Main results expected | November 30, 2023 |
| Study ends | December 2025 |
| Registry record updated | June 17, 2025 |
| Trial ID | NCT04114435 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants born at less than 29 weeks' gestational age who are admitted to the NICU.
✕Probably not a fit
Patients with congenital heart disease (other than minor defects), severe lung or airway malformations, or genetic disorders like Trisomy 21 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the cardiac performance and pulmonary vascular disease in infants born at less than 29 weeks of gestation. The researchers hypothesize that these premature infants experience compromised heart function and elevated pulmonary pressures, which may lead to increased morbidity and poorer neurodevelopmental outcomes. The study employs novel echocardiography techniques to detect cardiac anomalies that traditional imaging may miss, with the goal of identifying infants at risk for later pulmonary hypertension. The findings could provide insights into the long-term health of these vulnerable infants.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management strategies for extremely premature infants, potentially enhancing their long-term health outcomes.
How similar studies have gone: While this study employs novel echocardiography techniques, similar studies have indicated that early detection of cardiac issues in premature infants can lead to better outcomes, suggesting a promising avenue for further exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants born at \<29 weeks' gestational age admitted to the NICU * All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks Exclusion Criteria: * Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA)) * Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation) * Genetic disorder (Trisomy 21).
Where it's running
-
Mcgill University Health Centre
Montreal, Quebec, Canada Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Household, wellbeing, and quality-of-life impacts of very preterm birth and necrotising enterocolitis
This project will collect information to see if pausing or continuing milk feeds around blood transfusions relates to babies' quality of life and the financial and emotional impact on families of very preterm infants, especially those with NEC.
-
Giving surfactant to premature infants using a thin catheter at birth
This study is testing if giving a special lung treatment to very premature babies right after birth using a thin tube can help them breathe better and need less breathing support in their first few days of life.
-
Tracking intellectual and motor development in babies at high risk for cerebral palsy
This project will follow babies at higher risk for cerebral palsy to see if early thinking and movement signs predict later intellectual and motor outcomes.
-
Targeted fortification of donor breast milk for preterm infants
This study is testing if customizing the nutrients in donor breast milk helps preterm infants grow better than using regular methods.
-
Earlier use of an electric breast pump to maximize milk in preterm babies
This study tests whether starting a double electric breast pump earlier (at birth) helps mothers of very preterm infants produce more milk by day 14.
-
Adding azithromycin to ampicillin for late PPROM
This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.